ABBEY SPANIER, LLP ANNOUNCES CLASS ACTION LAWSUIT FILED AGAINST GNC, INC. IN CONNECTION WITH THE MARKETING AND SELLING OF CELLUCOR'S C-4 EXTREME

February 21, 2012, New York, N.Y. - Abbey Spanier, LLP announces that a class action lawsuit has been filed against General Nutrition Centers, Inc. ("GNC”), Cellucor Sports Nutrition, Woodbolt Distribution, Ltd, Woodbolt Management LLC and Woodbolt International for, among other things, violations of the California Consumer Leal Remedies Act, the California False Advertising Law, and the California Unfair Competition Act.  This action, filed in the United States District Court, Central District of California (Civil Action No. 12-1336), has been brought as a class action on behalf of all persons in the United States who purchased Cellucor’s C-4 Extreme at any time during the four years prior to the filing of this lawsuit (the “Class Period’).

The complaint alleges that during the Class Period, Defendants engaged in an illegal and deceptive practice of promoting, marketing, distributing and/or selling C-4 Extreme as a natural dietary supplement when, in fact, C-4 Extreme contains a dangerous substance known by many names, including “1,3 Dimethylamylamine,” “1,3 Dimethylhexaneamine HCl,” “1,3 Dimethylhexaneamine,” “Methylhexaneamine,” and “Geranamine” (known as “DMAA”).  Plaintiff alleges that Defendants failed to disclose that the DMAA contained in C-4 Extreme is wholly synthetic, manufactured and not derived from the geranium plant.

At the time Plaintiff and the class of consumers purchased and used C-4 Extreme, they were unaware that C-4 Extreme contained the synthetic and dangerous stimulant DMAA and that DMAA was not derived from the geranium plant or any other natural source.  Plaintiff alleges that the DMAA contained in C-4 Extreme is a synthetic product that is illegal and dangerous and has dangerous side effects.  The safety concerns associated with DMAA have been well-documented, including concerns that DMAA is a dangerous and addictive substance that can cause headache, nausea and stroke.  Experts have noted that DMAA has a chemical structure similar to amphetamines and ephedrine and can cause increases in heart rate and blood pressure and even death.

Click here to view Complaint

Karin E. Fisch ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) and Stephanie Amin-Giwner ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) represent the Plaintiff.

If you purchased Cellucor’s C-4 Extreme that you believe contained DMAA please call us.

Abbey Spanier, LLP
212 East 39th Street
New York, New York 10016
(212) 889-3700
(800) 889-3701 (Toll Free)